Cellectar Biosciences, Inc. Preferred Stock Dividends and Other Adjustments
Cellectar Biosciences, Inc. (CLRB) reported Preferred Stock Dividends and Other Adjustments of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2020-03-09
- Cellectar Biosciences, Inc. preferred stock dividends and other adjustments for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- Cellectar Biosciences, Inc. preferred stock dividends and other adjustments for the quarter ending 2018-09-30 was $2.24M.
- Cellectar Biosciences, Inc. preferred stock dividends and other adjustments for the quarter ending 2017-12-31 was $1.45M.
- Cellectar Biosciences, Inc. preferred stock dividends and other adjustments for the quarter ending 2017-09-30 was $0.00.
- Cellectar Biosciences, Inc. preferred stock dividends and other adjustments for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Cellectar Biosciences, Inc. preferred stock dividends and other adjustments for fiscal 2018 was $2.24M, a 54.72% increase from fiscal 2017.
- Cellectar Biosciences, Inc. preferred stock dividends and other adjustments for fiscal 2017 was $1.45M, a 54.44% decline from fiscal 2016.
- Cellectar Biosciences, Inc. preferred stock dividends and other adjustments for fiscal 2016 was $3.18M.
| Period end | Preferred Stock Dividends and Other Adjustments 3 month | Preferred Stock Dividends and Other Adjustments 6 month | Preferred Stock Dividends and Other Adjustments 9 month | Preferred Stock Dividends and Other Adjustments 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-09 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $2.24M derived: sum of 2 quarters · filed 2020-03-09 | $2.24M 10-K · filed 2020-03-09 | |
| 2018-09-30 | $2.24M 10-Q · filed 2019-11-12 | $2.24M 10-Q · filed 2019-11-12 | ||
| 2017-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.45M derived: sum of 2 quarters · filed 2019-02-26 | $1.45M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-13 | $0.00 10-Q · filed 2018-11-13 | ||
| 2016-12-31 | $3.18M 10-K · filed 2018-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |